Review Article
Volume 8 Issue 11 - 2021
Coffee Drinking and the Human Heart: Cardio-Supportive Effects of Accustomed Coffee-Consumption
Nicholas A Kerna1,2*, Sahalia Rashid3, Sudeep Chawla4, ND Victor Carsrud5, Joseph Anderson II6, Kevin D Pruitt7,8, John V Flores9,10 and Hilary M Holets9,10
1SMC-Medical Research, Thailand
2First InterHealth Group, Thailand
3All Saints University School of Medicine, Dominica
4Chawla Health and Research, USA
5Lakeline Wellness Center, USA
6International Institute of Original Medicine, USA
7Kemet Medical Consultants, USA
8PBJ Medical Associates, LLC, USA
9Beverly Hills Wellness Surgical Institute, USA
10Orange Partners Surgicenter, USA
*Corresponding Author: Nicholas A Kerna, (mailing address) POB47 Phatphong, Suriwongse Road, Bangkok, Thailand 10500. Contact: medpublab+drkerna@gmail.com.
Received: October 21, 2021; Published: October 30, 2021




Abstract

Coffee, second only to water, is the most consumed beverage among adults. It is also the primary source of dietary caffeine, having a high antioxidant content. Numerous bioactive compounds are present in coffee. Regular coffee consumption is associated with multiple health benefits, such as reducing the risk of type 2 diabetes mellitus, cancer, neurogenerative disorders, hepatic diseases, and cardiovascular diseases.

Various extensive epidemiological studies have shown that regular coffee consumption reduces mortality risks for all-cause and cardiovascular events. Contrarily, habitual consumption of coffee can lead to tolerance to caffeine and desensitize adenosine receptors responsible for the lack of pressor effects in these individuals.

Coffee’s adverse effects are linked to its diterpenes, cafestol, and kahweol, which are in high proportions—especially in unfiltered and boiled coffee—causing an elevation in serum and low-density lipoprotein cholesterol levels and increasing the risk of coronary heart disease. However, in filtered and instant coffee, the diterpenes are significantly less. Diterpenes demonstrate hepatoprotective benefits by exerting an antioxidant effect and decreasing the expression of inflammatory markers.

Coffee, when consumed excessively, can have adverse effects, while the benefits of coffee are not evident at a low consumption. Thus, a moderate 3–4 cups per day are recommended to receive optimal advantages—especially cardio-supportive effects. Furthermore, moderate consumption in people with a history of heart failure does not undermine health.

This review aims to update the reader on recent research regarding the health benefits of chronic coffee intake and its cardiosupportive effects at dietary doses.

Keywords: Antioxidant; Cancer; Caffeine; Cardiovascular; Neurodegenerative; Nonalcoholic Fatty Liver Disease; Parkinson’s Disease; Type 2 Diabetes Mellitus

References

  1. Global coffee consumption (2021). https://www.statista.com/statistics/292595/global-coffee-consumption/
  2. Fredholm BB. “Notes on the history of caffeine use”. Handbook of Experimental Pharmacology (2011): 1-9. https://www.researchgate.net/publication/46394171_Notes_on_the_History_of_Caffeine_Use
  3. Hajar R. “The Air of History (Part IV): Great Muslim Physicians Al Rhazes”. Gulf Heart Association. Address. Gulf Heart Association 14 (2013): 93-95. https://pubmed.ncbi.nlm.nih.gov/23983918/
  4. Namba T and Matsuse T. “[A historical study of coffee in Japanese and Asian countries: focusing the medicinal uses in Asian traditional medicines]”. Yakushigaku Zasshi 37 (2002): 65-75. https://pubmed.ncbi.nlm.nih.gov/12412599/
  5. Ludwig IA., et al. “Coffee: biochemistry and potential impact on health”. Food and Function 5 (2014): 1695-1717. https://pubmed.ncbi.nlm.nih.gov/24671262/
  6. Pourshahidi LK., et al. “A Comprehensive Overview of the Risks and Benefits of Coffee Consumption”. Comprehensive Reviews in Food Science and Food Safety 15 (2016): 671-684. https://www.researchgate.net/publication/301308535_A_Comprehensive_Overview_of_the_Risks_and_Benefits_of_Coffee_Consumption_Coffee_consumption_and_human_health
  7. Moura-Nunes N., et al. “The increase in human plasma antioxidant capacity after acute coffee intake is not associated with endogenous non-enzymatic antioxidant components”. International Journal of Food Sciences and Nutrition 60 (2009): 173-181. https://www.researchgate.net/publication/26808476_The_increase_in_human_plasma_antioxidant_capacity_after_acute_coffee_intake_is_not_associated_with_endogenous_non-enzymatic_antioxidant_components
  8. Yashin A., et al. “Antioxidant and Antiradical Activity of Coffee”. Antioxidants 2 (2013): 230-245. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4665516/
  9. Carlström M and Larsson SC. “Coffee consumption and reduced risk of developing type 2 diabetes: a systematic review with meta-analysis”. Nutrition Reviews 76 (2018): 395-417. https://pubmed.ncbi.nlm.nih.gov/29590460/
  10. Reis H., et al. “PD-L1 Expression in Urothelial Carcinoma With Predominant or Pure Variant Histology: Concordance Among 3 Commonly Used and Commercially Available Antibodies”. The American Journal of Surgical Pathology 43 (2019): 920-927. https://pubmed.ncbi.nlm.nih.gov/31135485/
  11. Van Dam RM and Feskens EJ. “Coffee consumption and risk of type 2 diabetes mellitus”. The Lancet 360 (2002): 1477-1478. https://pubmed.ncbi.nlm.nih.gov/12433517/
  12. Van Dam RM., et al. “Coffee consumption and incidence of impaired fasting glucose, impaired glucose tolerance, and type 2 diabetes: the Hoorn Study”. Diabetologia 47 (2004): 2152-2159. https://pubmed.ncbi.nlm.nih.gov/15662556/
  13. Teas, Cocoa and Coffee: Plant Secondary Metabolites and Health (2021). https://www.wiley.com/en-us/Teas%2C+Cocoa+and+Coffee%3A+Plant+Secondary+Metabolites+and+Health-p-9781444334418
  14. Klatsky AL., et al. “Coffee, caffeine, and risk of hospitalization for arrhythmias”. The Permanente Journal 15 (2011): 19-25. https://pubmed.ncbi.nlm.nih.gov/22058665/
  15. James JE. “Is habitual caffeine use a preventable cardiovascular risk factor?” The Lancet 349 (1997): 279-281. https://pubmed.ncbi.nlm.nih.gov/9014929/
  16. James JE. “Critical review of dietary caffeine and blood pressure: a relationship that should be taken more seriously”. Psychosomatic Medicine 66 (2004): 63-71. https://pubmed.ncbi.nlm.nih.gov/14747639/
  17. O’Keefe JH., et al. “Coffee for Cardioprotection and Longevity”. Progress in Cardiovascular Diseases 61 (2018): 38-42. https://pubmed.ncbi.nlm.nih.gov/29474816/
  18. Surma S and Oparil S. “Coffee and Arterial Hypertension”. Current Hypertension Reports 23 (2021): 38. https://pubmed.ncbi.nlm.nih.gov/34370111/
  19. Smits P., et al. “The cardiovascular effects of regular and decaffeinated coffee”. British Journal of Clinical Pharmacology 19 (1985): 852-854. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1463879/
  20. Wu J., et al. “Coffee consumption and risk of coronary heart diseases: a meta-analysis of 21 prospective cohort studies”. International Journal of Cardiology 137 (2009): 216-225. https://pubmed.ncbi.nlm.nih.gov/18707777/
  21. Gunter MJ., et al. “Coffee Drinking and Mortality in 10 European Countries: A Multinational Cohort Study”. Annals of Internal Medicine 167 (2017): 236-247. https://pubmed.ncbi.nlm.nih.gov/28693038/
  22. Stevens LM., et al. “Association Between Coffee Intake and Incident Heart Failure Risk”. Circulation: Heart Failure American Heart Association 14 (2021): e006799. https://pubmed.ncbi.nlm.nih.gov/33557575/
  23. Larsson SC and Orsini N. “Coffee Consumption and Risk of Stroke: A Dose-Response Meta-Analysis of Prospective Studies”. American Journal of Epidemiology 174 (2011): 993-1001. https://pubmed.ncbi.nlm.nih.gov/21920945/
  24. Anty R., et al. “Regular coffee but not espresso drinking is protective against fibrosis in a cohort mainly composed of morbidly obese European women with NAFLD undergoing bariatric surgery”. The Journal of Hepatology 57 (2012): 1090-1096. https://pubmed.ncbi.nlm.nih.gov/22820478/
  25. Saab S., et al. “Impact of coffee on liver diseases: a systematic review”. Liver international: official journal of the International Association for the Study of the Liver 34 (2014): 495-504. https://pubmed.ncbi.nlm.nih.gov/24102757/
  26. Zhou A and Hyppönen E. “Long-term coffee consumption, caffeine metabolism genetics, and risk of cardiovascular disease: a prospective analysis of up to 347,077 individuals and 8368 cases”. The American Journal of Clinical Nutrition 109 (2019): 509-516. https://pubmed.ncbi.nlm.nih.gov/30838377/
  27. Temple JL., et al. “The Safety of Ingested Caffeine: A Comprehensive Review”. Frontiers in Psychiatry 8 (2017): 80. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445139/
  28. Wijarnpreecha K., et al. “Coffee consumption and risk of nonalcoholic fatty liver disease: a systematic review and meta-analysis”. European Journal of Gastroenterology and Hepatology 29 (2017): e8-12. https://pubmed.ncbi.nlm.nih.gov/27824642/
  29. Zhang Y-P., et al. “Systematic review with meta-analysis: coffee consumption and the risk of gallstone disease”. Alimentary Pharmacology and Therapeutics 42 (2015): 637-648. https://pubmed.ncbi.nlm.nih.gov/26198295/
  30. Iriondo-DeHond A., et al. “Effects of Coffee and Its Components on the Gastrointestinal Tract and the Brain-Gut Axis”. Nutrients 13 (2020): E88. https://pubmed.ncbi.nlm.nih.gov/33383958/
  31. Lire Wachamo H. “Review on Health Benefit and Risk of Coffee Consumption”. Medicinal and Aromatic Plants (2017). https://www.longdom.org/open-access/review-on-health-benefit-and-risk-of-coffee-consumption-2155-9821-1000301.pdf
  32. Jarvis MJ. “Does caffeine intake enhance absolute levels of cognitive performance?” Psychopharmacology 110 (1993): 45-52. https://pubmed.ncbi.nlm.nih.gov/7870897/
  33. Mathew B., et al. “Emerging therapeutic potentials of dual-acting MAO and AChE inhibitors in Alzheimer’s and Parkinson’s diseases”. Archiv der Pharmazie 352 (2019): e1900177. https://pubmed.ncbi.nlm.nih.gov/31478569/
  34. Lee M., et al. “Quercetin, not caffeine, is a major neuroprotective component in coffee”. Neurobiol Aging 46 (2016): 113-123. https://www.researchgate.net/publication/304814728_Quercetin_not_caffeine_is_a_major_neuroprotective_component_in_coffee
  35. Poole R., et al. “Coffee consumption and health: umbrella review of meta-analyses of multiple health outcomes”. British Medical Journal 359 (2017): j5024. https://www.bmj.com/content/359/bmj.j5024
  36. Liu J., et al. “Association of Coffee Consumption With All-Cause and Cardiovascular Disease Mortality”. Mayo Clinic Proceedings 88 (2013): 1066-1074. https://pubmed.ncbi.nlm.nih.gov/23953850/
  37. Bertasi RAO., et al. “Caffeine Intake and Mental Health in College Students”. Cureus 13 (2020): e14313. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099008/
  38. Clementz GL and Dailey JW. “Psychotropic effects of caffeine”. American Family Physician 37 (1988): 167-172. https://pubmed.ncbi.nlm.nih.gov/3284301/
  39. Pigozzi MT., et al. “Quality of Commercial Coffees: Heavy Metal and Ash Contents”. Journal of Food Quality Hindawi (2018): e5908463. https://www.hindawi.com/journals/jfq/2018/5908463/
  40. Nędzarek A., et al. “Concentrations of heavy metals (Mn, Co, Ni, Cr, Ag, Pb) in coffee”. Acta Biochimica Polonica (2013): 60. https://pubmed.ncbi.nlm.nih.gov/24340307/
  41. Toschi TG., et al. “Coffee silverskin: characterization, possible uses, and safety aspects”. Journal of Agricultural and Food Chemistry 62 (2014): 10836-10844. https://pubs.acs.org/doi/10.1021/jf503200z
  42. Nawrot P., et al. “Effects of caffeine on human health”. Food Additives and Contaminants 20 (2003): 1-30. https://pubmed.ncbi.nlm.nih.gov/12519715/
  43. Ribeiro EM., et al. “Safety of coffee consumption after myocardial infarction: A systematic review andmeta-analysis”. Nutrition, Metabolism and Cardiovascular Diseases 30 (2020): 2146-2158. https://pubmed.ncbi.nlm.nih.gov/33158718/
  44. Cornelis MC and El-Sohemy A. “Coffee, caffeine, and coronary heart disease”. Current Opinion in Clinical Nutrition and Metabolic Care 10 (2007): 745-751. https://pubmed.ncbi.nlm.nih.gov/17218826/
Citation: Kerna NA, Rashid S, Chawla S, Carsrud NDV, Anderson II J, Pruitt KD, Flores JV, Holets HM. “Coffee Drinking and the Human Heart: Cardio-Supportive Effects of Accustomed Coffee-Consumption”. EC Cardiology 8.11 (2021): 30-38.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


December Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the November issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before December 21, 2022.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.